Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novaliq
Biotech
Bausch-Novaliq's eye drop beats placebo again in phase 3 trial
Patients with dry eye disease taking Bausch + Lomb's eye drop reported an improvement in the severity of eye dryness during a phase 3 clinical trial.
Kyle LaHucik
Sep 30, 2021 11:00am
Chutes & Ladders—Allergan vet to replace Kaye as Sarepta’s CEO
Jun 30, 2017 7:33am
Ophthalmic CRO Ora kept in ocular clinical trial pact with Axim
Mar 29, 2017 2:19pm
